Neuroone Medical Technologies (NMTC) Accumulated Expenses (2011 - 2026)
Neuroone Medical Technologies (NMTC) posted Accumulated Expenses of $755258.0 for Q1 2026, up 6.96% on a QoQ basis from $706112.0 in Q4 2025, and down 11.42% year-over-year from $852587.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Accumulated Expenses (2011 - 2026) Analysis & Trends
Neuroone Medical Technologies' Accumulated Expenses history runs 15 years deep, the most recent figure standing at $755258.0 for Q1 2026.
- Quarterly Accumulated Expenses fell 11.42% year-over-year to $755258.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $755258.0 (down 11.42% YoY) and the FY2025 annual result came in at $1.3 million, up 9.18% from the prior year.
- Accumulated Expenses was $755258.0 for Q1 2026 at Neuroone Medical Technologies, up from $706112.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $1.3 million in Q3 2025 and bottomed at $322546.0 in Q4 2024.
- A 5-year average of $732602.0 and a median of $715839.0 in 2022 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Accumulated Expenses retreated 28.03% — and 2025, when it jumped 118.92%.
- Neuroone Medical Technologies' Accumulated Expenses stood at $473085.0 in 2022, then dropped by 28.03% to $340490.0 in 2023, then dropped by 5.27% to $322546.0 in 2024, then surged by 118.92% to $706112.0 in 2025, then gained by 6.96% to $755258.0 in 2026.
- Business Quant data shows NMTC's Accumulated Expenses at $755258.0 in Q1 2026, $706112.0 in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Neuroone Medical Technologies | 15.70 Mn | 12.90 Mn | 990,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 755,258.00 |
| Dec 31, 2025 | 706,112.00 |
| Sep 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 958,056.00 |
| Mar 31, 2025 | 852,587.00 |
| Dec 31, 2024 | 322,546.00 |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 931,700.00 |
| Mar 31, 2024 | 579,071.00 |
| Dec 31, 2023 | 340,490.00 |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 789,097.00 |
| Mar 31, 2023 | 596,940.00 |
| Dec 31, 2022 | 473,085.00 |
| Sep 30, 2022 | 715,839.00 |
| Jun 30, 2022 | 487,244.00 |
| Mar 31, 2022 | 361,959.00 |
| Dec 31, 2021 | 356,374.00 |
| Sep 30, 2021 | 644,249.00 |
| Jun 30, 2021 | 436,846.00 |